Skip to main content

Development of a CZE Method for the Determination of Olmesartan Medoxomil in Tablets


A CZE method was developed and validated for the analysis of Olmesartan medoxomil (OLMD) in tablets. The influences of pH, buffer concentration, applied voltage and capillary temperature on the migration time of OLMD were investigated. About 50 mM pH 6.5 phosphate buffer were used as background electrolyte. The optimum instrument parameters were found to be 30 °C temperature with 30 kV applied voltage and diode array detection was carried out at 210 nm. OLMD was hydrodynamically injected (P inj  = 50 mbar, t inj  = 3 s) and an internal standard, diflunisal (IS), was used to improve the precision and repeatability. Under these conditions, the migration time of OLMD was 2.32 min and the total analysis time was shorter than 5 min. Linearity range for the developed method was found to be 2.0–50.0 μg mL−1 and the limit of detection was 0.5 μg mL−1. The developed method was applied for the analysis of OLMD in pharmaceutical tablet formulations.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2


  1. Koike H, Konse T, Sada T, Ikeda T, Hyogo S, Hinman D, Saito H, Yanagisawa H (2003) Ann Rep Sankyo Res Lab 55:1–91

    CAS  Google Scholar 

  2. Mire DE, Silfani TN, Pugsley MK (2005) J Cardiovasc Pharm 46:585–593

    Article  CAS  Google Scholar 

  3. Kobayashi N, Fujimori I, Watanabe M, Ikeda T (2000) Anal Biochem 287:272–278

    Article  CAS  Google Scholar 

  4. Yanagisawa H, Amemiya Y, Kanazaki T, Shimoji Y, Fujimoto K, Kitahara Y, Sada T, Mizuno M, Ikeda M, Miyamoto S, Furukawa Y, Koike H (1996) J Med Chem 39:323–338

    Article  CAS  Google Scholar 

  5. Web page about the chemical and physical properties of Olmesartan Medoxomil:

  6. Unger T, McInnes GT, Neutel JM, Böhm M (2004) Drugs 64:2731–2739

    Article  CAS  Google Scholar 

  7. Altria KD, Chen AB, Clohs L (2001) LCGC North America 19:972, 974, 976, 978, 980, 982, 984–985

  8. Morzunova TG (2006) Pharm Chem J 40:158–170

    Article  CAS  Google Scholar 

  9. Holzgrabe U (2005) Pharm Ind 67:1209–1213

    CAS  Google Scholar 

  10. Holzgrabe U, Brinz D, Kopec S, Weber C, Bitar Y (2006) Electrophoresis 27:2283–2292

    Article  CAS  Google Scholar 

  11. Bardelmeijer HA, Lingeman H, De Ruiter C, Underberg WJ (1998) J Chromatogr A 807:3–26

    Article  CAS  Google Scholar 

  12. Gonzalez L, Akesolo U, Jimenez RM, Alonso RM (2002) Electrophoresis 23:223–229

    Article  CAS  Google Scholar 

  13. Hillaert S, Van den Bossche W (2002) J Chromatogr A 979:323–333

    Article  CAS  Google Scholar 

  14. Celebier M, Altinoz S (2007) Die Pharm 62:419–422

    CAS  Google Scholar 

  15. ICH (2005) Steering Committee. Validation of analytical procedures: Text and Methodology Q2(R1). Harmonized Tripartite Guideline

  16. Fabre H, Altria K (2001) LC–GC 302–310

  17. Taverniers I, Loose MD, Bockstaele EV (2004) Trends Anal Chem 23:480–490

    Article  CAS  Google Scholar 

  18. Taverniers I, Loose MD, Bockstaele EV (2004) Trends Anal Chem 23:535–552

    Article  CAS  Google Scholar 

  19. Mayer BX (2001) J Chromatogr A 907:21–37

    Article  CAS  Google Scholar 

  20. Hansen HK, Hansen SH, Kraunsoe M, Petersen GM (1999) Eur J Pharm Sci 9:41–46

    Article  CAS  Google Scholar 

Download references


The authors thank Daiichi Sankyo for their kind supply of pure Olmesartan Medoxomil and Pfizer to supply Olmetec® (10, 20, 40 mg) tablets.

Author information

Authors and Affiliations


Corresponding author

Correspondence to Sacide Altinöz.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Çelebier, M., Altinöz, S. Development of a CZE Method for the Determination of Olmesartan Medoxomil in Tablets. Chroma 66, 929–933 (2007).

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: